MRNS | Marinus Pharmaceuticals Inc
Category: Consumer goods
Quick infos Headquarters: Radnor, Pennsylvania, United States Trade prices Volume: Market Cap: 176.79M Prev closed: Open: 8.59 High: 12.37 Low: 8.5 52 week low: 7.16 52 week high: 19.83 Dividends: No Dividends Next ER: November 7, 2022
Earnings History Date EPS / Forecast Revenue / Forecast March 13, 2023 November 7, 2022 1.89 / -0.98862.34M / 3.01MAugust 11, 2022 -1.06 / -0.911.79M / 2.28MMay 12, 2022 -0.52 / -0.83914.19M / 2.27MBeat! March 21, 2022 -0.77 / -0.7611.52M / 3.37Mview more
Historical Data Date Price Open High Low Vol Change ER Aug 11, 2022 5.77 6.00 6.09
5.70
165.00K -2.7% Aug 10, 2022 5.93 5.64 5.98
5.50
385.21K 8.41% Aug 9, 2022 5.47 5.66 5.87
5.36
293.38K -3.87% Aug 8, 2022 5.69 5.61 5.92
5.50
130.29K 2.34% Aug 5, 2022 5.56 5.45 5.63
5.40
187.55K 1.28% Aug 4, 2022 5.49 5.47 5.57
5.38
76.92K 2.04% Aug 3, 2022 5.38 5.41 5.51
5.34
110.34K 1.89% Aug 2, 2022 5.28 5.11 5.41
5.03
133.37K 2.13% Aug 1, 2022 5.17 5.51 5.54
5.14
611.57K -7.18% Jul 29, 2022 5.57 5.86 5.86
5.42
155.88K -3.8% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:January 1, 2003 Employees:100 News
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results finance.yahoo.com Aug 30, 2022 4:04 pm
Marinus Pharmaceuticals Announces FDA Approval of ZTALMY® (ganaxolone) for CDKL5 Deficiency Disorder finance.yahoo.com Aug 30, 2022 2:29 pm
Marinus Files US Application For Ganaxolone For Genetic Epilepsy, Inks European Commercialization Pact With Orion finance.yahoo.com Aug 30, 2022 9:28 am
Marinus Pharmaceuticals Joins the Loulou Foundation in Collaboration on CANDID, a Comprehensive Observational Study in CDKL5 Deficiency Disorder finance.yahoo.com Aug 30, 2022 8:01 am Marinus Pharma closes on sale of a U.S. FDA priority review voucher for $110M seekingalpha.com Aug 30, 2022 4:16 am Marinus Pharmaceuticals GAAP EPS of -$1.06 misses by $0.37, revenue of $1.8M misses by $0.51M seekingalpha.com Aug 11, 2022 7:34 pm Marinus Pharmaceuticals Q2 2022 Earnings Preview seekingalpha.com Aug 11, 2022 1:49 am
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) finance.yahoo.com Jul 15, 2022 4:05 pm
Marinus selling rare pediatric disease priority review voucher for $110M bizjournals.com Jul 14, 2022 11:07 am
What Type Of Shareholders Make Up Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Share Registry? finance.yahoo.com Jun 25, 2022 10:34 am
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) finance.yahoo.com Jun 3, 2022 4:01 pm
Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences finance.yahoo.com May 18, 2022 9:00 am
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) finance.yahoo.com Aug 30, 2022 8:00 am
Marinus Pharmaceuticals Bolsters Leadership Team with Two New Appointments finance.yahoo.com Aug 30, 2022 7:30 am
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results finance.yahoo.com Aug 30, 2022 7:30 am
Marinus Pharmaceuticals Announces Resumption of Phase 3 RAISE Trial in Status Epilepticus finance.yahoo.com Aug 30, 2022 7:30 am
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results finance.yahoo.com Aug 30, 2022 7:30 am
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results finance.yahoo.com Aug 30, 2022 7:15 am
Marinus Pharmaceuticals Submits New Drug Application (NDA) to FDA for Ganaxolone for the Treatment of Seizures Associated with CDKL5 Deficiency Disorder and Provides Pipeline Update finance.yahoo.com Aug 30, 2022 7:05 am
Marinus Pharmaceuticals Appoints Dr. Saraswathy (Sara) Nochur to Board of Directors finance.yahoo.com Aug 30, 2022 7:00 am This company doesn't provide a dividend.
Key Persons CFO : Steven E. Pfanstiel General Counsel : Martha Manning Talk about Marinus Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology